Eclipsys Corporation announced that Singapore General Hospital (SGH), has activated Eclipsys' Sunrise Patient Flow(TM) solution. The on-time, on-budget technology, automation and process redesign project illustrates how Eclipsys' integrated and intuitive bed management, bed turnover and patient flow system can quickly bring operational improvements to even the most complex healthcare organizations. SGH is using Sunrise Patient Flow to improve the workflows and communications of its clinical, administrative and support staff. Combined with real-time clinical visibility, the solution is yielding substantial clinical and operational advantages as it supports the goal of optimized patient throughput and efficient delivery of patient care. The 'big bang' activation of Sunrise Patient Flow was completed in approximately five months and without any major disruption in SGH's care delivery.

Eclipsys Corporation announced that North Mississippi Medical Center (NMMC) has selected the Eclipsys' Sunrise Enterprise(TM) integrated suite of solutions. The major technology upgrade, which represents one of the largest contracts in recent Eclipsys company history, will span NMMC's seven acute care facilities to enhance the quality of system-wide electronic health records (EHRs) for faster, more informed clinical decision making. It also helps to position the health system to meet the expected 'meaningful use' definition of the American Recovery and Reinvestment Act (ARRA) and qualify for maximum stimulus payment opportunities.

Eclipsys Corporation reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2009. Revenues for the quarter ended September 30, 2009 were $125.5 million, compared to revenues of $132.4 million for the quarter ended September 30, 2008. GAAP net income available to common shareholders for the third quarter was 2009 was $3.9 million, or $0.07 per diluted common share, compared to GAAP net income available to common shareholders of $86.4 million, or $1.58 per share on a diluted basis for the third quarter of 2008. GAAP net income in the third quarter of 2008 included a one-time income tax benefit of $80.0 million associated with the reversal of the company's deferred tax valuation allowance. Non-GAAP net income for the third quarter of 2009 was $8.2 million, or $0.14 per diluted common share, compared to third quarter 2008 non-GAAP net income of $16.3 million, or $0.30 per diluted share. Income from operations was $4.5 million against $6.8 million for the same period of last year. Income before income taxes was $4.1 million against $8.1 million for the same period of last year. Net cash provided by operating activities was $32.4 million against $34.9 million for the same period of last year. Purchases of property and equipment was $5.0 million against $7.1 million for the same period of last year. On Non-GAAP basis, the company reported operating income of $12.9 million, pre-tax income of $13.5 million on total revenue of $126.1 million against operating income of $15.8 million, pre-tax income of $17.2 million on total revenue of $132.4 million for the same period of last year. For the nine months, the company reported income from operations of $2.2 million, income before income taxes of $2.9 million and net loss available to common shareholders of $1.1 million or $0.02 per diluted share on total revenue of $385.5 million against income from operations of $11.9 million, income before income taxes of $19.6 million and net income available to common shareholders of $95.1 million or $1.74 per diluted share on total revenue of $388.9 million for the same period of last year. Net cash provided by operating activities was $70.2 million against $41.5 million for the same period of last year. Purchases of property and equipment was $17.6 million against $20.4 million for the same period of last year. On Non-GAAP basis, the company reported operating income of $41.1 million, pre-tax income of $42.99 million and net income of $26.7 million or $0.47 per diluted share on total revenue of $391.4 million against operating income of $35.1 million, pre-tax income of $39.4 million and net income of $37.6 million or $0.68 per diluted share on total revenue of $388.9 million for the same period of last year. The company announced that the non-GAAP earnings per share guidance range remains $0.55 to $0.60 for 2009.